Research.Patient.info
ER+ HER2- Advanced Breast Cancer research hub
2 indexed studies · 1 currently recruiting
- recruitingPHASE1, PHASE2
A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors
This study looks at a new drug, AZD8421, for advanced breast cancer (ER+ HER2- type) and a type of ovarian cancer. It checks how safe and effective it is, sometimes alone and sometimes with other cancer medicines.
United States · Australia · South Korea - active not recruitingPHASE1
Study of AZD9833 Alone or in Combination in Women With Advanced Breast Cancer.
This study is looking into a new medicine, AZD9833, for women with advanced breast cancer that is hormone-sensitive (ER+) but not HER2-positive. It's testing AZD9833 alone or with other common cancer drugs to see if it's safe and how well it works.
United States · Spain · United Kingdom